Not applicableStudy completedNCT03880643What this trial is testingRituximab in Refractory Primary Membranous NephropathyWho this might be right forGlomerulonephritis, Membranous Istanbul University 36
Not applicableStudy completedNCT05788211What this trial is testingREnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)Who this might be right forCardiogenic ShockRenal Replacement TherapyVenoarterial Extracorporeal Membrane Oxygenation University Hospital, Bordeaux 93
Very early researchNot Yet RecruitingNCT07389499What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney DiseasesWho this might be right forIgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more Grit Biotechnology 30
Early research (Phase 1)Looking for participantsNCT07266181What this trial is testingSafety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous NephropathyWho this might be right forRefractory Membranous Nephropathy The First Affiliated Hospital of Air Force Medicial University 5
Very early researchNot Yet RecruitingNCT07423572What this trial is testingClinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)Who this might be right forRefractory Idiopathic Membranous Nephropathy The First Affiliated Hospital of Zhejiang Chinese Medical University 18
Early research (Phase 1)Not Yet RecruitingNCT07234474What this trial is testingA Phase I Study of YK012 in Primary Membranous NephropathyWho this might be right forPrimary Membranous Nephropathy Excyte Biopharma Ltd 66
Very early researchNot Yet RecruitingNCT07535138What this trial is testingEfficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune NephropathyWho this might be right forMembranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN) Air Force Military Medical University, China 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765537What this trial is testingA Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous NephropathyWho this might be right forPrimary Membranous Nephropathy Shenzhen Fosun Kairos Biotechnology Co., Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT04893096What this trial is testingMOR202 for Refractory MNWho this might be right forMembranous Nephropathy Mario Negri Institute for Pharmacological Research 10